Coloplast A/S ADR | |
Stock Exchange | Other OTC |
EPS |
$0.29 |
Market Cap |
$23.09 B |
Shares Outstanding |
1.98 B |
Public Float |
- |
Coloplast A/S Series B | |
Stock Exchange | Copenhagen Stock Exchange |
EPS |
DKK18.8 |
Market Cap |
DKK167.76 B |
Shares Outstanding |
198 M |
Public Float |
133.08 M |
Coloplast A/S Series B | |
Stock Exchange | Frankfurt Stock Exchange |
EPS |
EUR2.41 |
Market Cap |
EUR19.53 B |
Shares Outstanding |
198 M |
Public Float |
- |
Address |
Holtedam 1-3 Humlebæk ZE 3050 Denmark |
Employees | - |
Website | http://www.coloplast.com |
Updated | 07/08/2019 |
Coloplast A/S develops, manufactures, and markets medical products. It operates through the following segments: Chronic Care; Urology Care; and Wound and Skin Care. The Chronic Care segment covers the sale of ostomy care products and continence care products. |